日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET

在RET突变阳性甲状腺髓样癌患者中,针对selpercatinib的单臂LIBRETTO-001试验的真实世界外部对照组:RECALIB-RET

Hadoux, J; Hernando, J; Wong, K H; Do Cao, C; Lasolle, H; Buffet, C; Benisvy, D; Illouz, F; Schneegans, O; Varnier, R; Drui, D; Zanetta, S; Hescot, S; Muller, M; Nascimento, C; Roudaut, N; Khanal, M; Zheng, S; Li, X; Singh, R; Tian, W; Afonso, A S; Houot, B; Borget, I; Segall, G

Efficiency of Gla-300 versus Gla-100 Across Age Groups in People Living with Type 2 Diabetes in France: A Post Hoc Analysis of an Observational Longitudinal Study

法国2型糖尿病患者各年龄组中Gla-300与Gla-100疗效的比较:一项观察性纵向研究的事后分析

Darmon, Patrice; Hanon, Olivier; Gourdy, Pierre; Borget, Isabelle; Detournay, Bruno; Evenou, Pierre; Bureau, Isabelle; Allali, Noemie; Mahieu, Aymeric; Emery, Corinne; Penfornis, Alfred

Healthcare resource utilization and costs in immunodeficient patients receiving subcutaneous Ig: Real-world evidence from France

接受皮下注射免疫球蛋白治疗的免疫缺陷患者的医疗资源利用和成本:来自法国的真实世界证据

Lefèvre, Guillaume; Borget, Isabelle; Lefèvre, Cinira; Maherzi, Chahrazed; Nucit, Arnaud; Hennaoui, Mouna; Schmidt, Aurélie; Lennon, Hannah; Grenier, Benjamin; Daydé, Florent; Mahlaoui, Nizar

Clinical benefit of anti-PD-(L)1 immunotherapies in advanced cancer in France: a population-based estimate from 2014 to 2021

法国晚期癌症患者接受抗PD-(L)1免疫疗法的临床获益:2014年至2021年基于人群的估计

Grumberg, V; Cotté, F-E; Giroux-Leprieur, E; Gaudin, A-F; Lebbé, C; Borget, I

Suitability of the Current Health Technology Assessment of Innovative Artificial Intelligence-Based Medical Devices: Scoping Literature Review

当前健康技术评估对创新型人工智能医疗器械的适用性:范围界定文献综述

Farah, Line; Borget, Isabelle; Martelli, Nicolas; Vallee, Alexandre

Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study

法国糖尿病患者基础胰岛素治疗:EF-BI 研究

Gourdy, Pierre; Darmon, Patrice; Borget, Isabelle; Emery, Corinne; Bureau, Isabelle; Detournay, Bruno; Bahloul, Amar; Allali, Noemie; Mahieu, Aymeric; Penfornis, Alfred

Correction to: Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study

更正:法国糖尿病患者基础胰岛素治疗:EF-BI 研究

Gourdy, Pierre; Darmon, Patrice; Borget, Isabelle; Emery, Corinne; Bureau, Isabelle; Detournay, Bruno; Bahloul, Amar; Allali, Noemie; Mahieu, Aymeric; Penfornis, Alfred

Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France

法国一项全国性调查揭示了医院对创新医疗器械的健康技术评估:

Martin, Tess; Guercio, Alessandra; Besseau, Hélène; Huot, Laure; Guerre, Pascale; Atfeh, Jamal; Piazza, Laurent; Pineau, Judith; Sabatier, Brigitte; Borget, Isabelle; Martelli, Nicolas

Organizational Impact of Immunotherapies in Advanced Cancers in France

免疫疗法对法国晚期癌症治疗机构的影响

Grumberg, Valentine; Chouaïd, Christos; Gaudin, Anne-Françoise; Le Tourneau, Christophe; Marabelle, Aurélien; Bongiovanni-Delarozière, Isabelle; Cotté, François-Emery; Borget, Isabelle

ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial

评估预防性中央区颈部淋巴结清扫术对改善低危分化型甲状腺癌预后的作用:一项前瞻性随机试验

Hartl, Dana; Godbert, Yann; Carrat, Xavier; Bardet, Stéphane; Lasne-Cardon, Audrey; Vera, Pierre; Ilies, Elena; Zerdoud, Slimane; Sarini, Jérôme; Zalzali, Mohamad; La Manna, Luigi; Schneegans, Olivier; Kelly, Antony; Kauffmann, Philppe; Rodien, Patrice; Brunaud, Laurent; Grunenwald, Solange; Housseau, Elie; Laghouati, Salim; Bouvet, Nathalie; Lecerf, Elodie; Hadoux, Julien; Lamartina, Livia; Schlumberger, Martin; Borget, Isabelle